In 2020, firms expected their innovation expenditures to decrease by about 2% in 2020 compared to 2019. This decline is … much smaller than that in 2009 following the financial crisis, when innovation expenditures fell by 11%. However, smaller … firms with 5 to 99 employees planned to cut their innovation expenditures by 7% to 17 % in 2020. For 2021, firms planned a …

This study analyses 1400 research projects of the top 20 R&D-spending pharmaceuticals to identify the determinants of …

are expected to experience accelerated growth due to innovation in the bioeconomy. Associated benefits and risks for … that expectation patterns in more recent fields of bio-based innovation are subject to early “hype cycle” dynamics. Our …

Die Pharmaindustrie im Allgemeinen und vor allem die Gruppe der forschenden Pharma-Unternehmen zeigen im aktuellen … betrachteten Referenzbranchen. Im letzten konjunkturellen Abschwung weist die Pharmaindustrie jedoch einen deutlichen … Beschäftigungsrückgang auf, der mit Sondereinflüssen zu erklären ist. In einer längerfristigen Betrachtung zeigen Pharmaindustrie und …

We calculate a novel international measure of pharmaceutical innovation power by focusing on global medical …

This paper analyses the link between sustainability-related innovation and sustainability performance and the role that … that are family-owned. Governments often support environmentally and socially beneficial innovation with various policy … will foster such innovation in their organisation. Hence the main research question of this paper is about the association …

of pharmaceutical learning and innovation and the interest of public health are best served in a framework where rigorous …